Tredje AP fonden Cuts Holdings in Envision Healthcare Corporation (NYSE:EVHC)

Cornelia Mascio
Settembre 21, 2017

Envision Healthcare Corporation (NYSE:EVHC) has declined 23.31% since September 19, 2016 and is downtrending. Livforsakringsbolaget Skandia Omsesidigt bought a new stake in Envision Healthcare Corporation during the 1st quarter valued at approximately $135,000. First Interstate Bank acquired a new position in Envision Healthcare Corporation in the first quarter worth about $184,000. Finally, Daiwa Securities Group Inc. boosted its stake in Envision Healthcare Corporation by 60.9% during the 1st quarter. The stock has performed -14.28% over the last seven days, -14.14% over the last thirty, and -25.85% over the last three months.

Several research analysts have weighed in on the stock. Finally, Canaccord Genuity restated a buy rating on shares of Envision Healthcare Corporation in a research note on Friday, December 9th. Jefferies Group LLC set a $71.00 price target on shares of Envision Healthcare Corporation and gave the company a "buy" rating in a report on Thursday, August 24th. The average investment rating for EVHC on a scale of 1 to 5 (1 being a strong sell and 5 being a strong buy) is a 4.79 or a Moderate Buy. Envision Healthcare Corporation has an average rating of "Buy" and a consensus target price of $71.56. Envision Healthcare Corporation has had 6 insider trades in the last 3 months, including 2 open market buys and 4 sells. The stock was sold at an average price of $62.69, for a total transaction of $94,035.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link.

Envision Healthcare Corporation (EVHC) traded down 1.69% on Monday, hitting $47.67. (EVHC) has the trading volume of 11.21 Million shares with the average trading volume of 3380 shares. The firm has a market capitalization of $3.76 billion, a PE ratio of 21.60 and a beta of 0.75.

Envision Healthcare Corporation (EVHC) stock's current distance from 20-Day Simple Moving Average is -14.53% and moving -20.70% away from 50-Day Simple Moving Average while traded down -29.11% from 200-Day Simple Moving Average.

Examining insider trading at Envision Healthcare Corporation (NYSE:EVHC) can provide us with excellent insight into how the company's stock is performing. The company reported $0.79 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.75 by $0.04. The firm had revenue of $1.95 billion for the quarter, compared to analysts' expectations of $1.96 billion. Envision Healthcare Corporation had a negative net margin of 7.35% and a positive return on equity of 5.35%. The firm's quarterly revenue was up 156.7% on a year-over-year basis. It last reported revenues of $1.95 billion and EPS of $0.85 for the June 2017, representing 157% top-line growth and 1.1 EPS growth. This buyback authorization authorizes the company to repurchase up to 4.5% of its shares through open market purchases. Symphony Asset Management LLC now owns 29,720 shares valued at $754,000.

ILLEGAL ACTIVITY NOTICE: This report was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are reading this piece on another site, it was illegally stolen and reposted in violation of global copyright and trademark law. The correct version of this report can be accessed at https://www.truebluetribune.com/2017/09/20/tredje-ap-fonden-sells-2395-shares-of-envision-healthcare-corporation-evhc.html.

Altre relazioniGrafFiotech

Discuti questo articolo

Segui i nostri GIORNALE